Crossmark

Predicting Tumor Volume Doubling Time and Progression-Free Survival in Untreated Patients from Patient-Derived-Xenograft (PDX) Models: A Translational Model-Based Approach

Crossref DOI link: https://doi.org/10.1208/s12248-024-00960-4

Published Online: 2024-08-08

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Tosca, E. M. https://orcid.org/0000-0002-9801-2135
Ronchi, D.

Rocchetti, M.

Magni, P. https://orcid.org/0000-0002-8931-4676
Funding

Funding for this research was provided by:

Università degli Studi di Pavia
License Information

Text and Data Mining valid from 2024-08-08

Version of Record valid from 2024-08-08
More Information

Article History

Received: 13 March 2024

Accepted: 24 July 2024

First Online: 8 August 2024

Declarations

:

: The authors have no conflicts of interest to declare.

Document is current

Any future updates will be listed below